Related references
Note: Only part of the references are listed.A Multiple-Imputation-Based Approach to Sensitivity Analyses and Effectiveness Assessments in Longitudinal Clinical Trials
Birhanu Teshome Ayele et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2014)
Estimation of the treatment effect in the presence of non-compliance and missing data
Ann-Kristin Leuchs et al.
STATISTICS IN MEDICINE (2014)
Recent Developments in the Prevention and Treatment of Missing Data
C. Mallinckrodt et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2014)
ANALYSIS OF LONGITUDINAL TRIALS WITH PROTOCOL DEVIATION: A FRAMEWORK FOR RELEVANT, ACCESSIBLE ASSUMPTIONS, AND INFERENCE VIA MULTIPLE IMPUTATION
James R. Carpenter et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2013)
A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials
C. H. Mallinckrod et al.
PHARMACEUTICAL STATISTICS (2013)
Missing data in clinical trials: from clinical assumptions to statistical analysis using patternmixture models
Bohdana Ratitch et al.
PHARMACEUTICAL STATISTICS (2013)
The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It
R. T. O'Neill et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
A structured approach to choosing estimands and estimators in longitudinal clinical trials
C. H. Mallinckrodt et al.
PHARMACEUTICAL STATISTICS (2012)
Addressing Missing Data in Clinical Trials
Thomas R. Fleming
ANNALS OF INTERNAL MEDICINE (2011)
Aspects of Modernizing Drug Development Using Clinical Scenario Planning and Evaluation
Norbert Benda et al.
DRUG INFORMATION JOURNAL (2010)
Conceptual Considerations Regarding Endpoints, Hypotheses, and Analyses for Incomplete Longitudinal Clinical Trial Data
Craig H. Mallinckrodt et al.
DRUG INFORMATION JOURNAL (2009)
Incomplete Data in Clinical Studies: Analysis, Sensitivity, and Sensitivity Analysis
Geert Molenberghs
DRUG INFORMATION JOURNAL (2009)
Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials
Craig H. Mallinckrodt et al.
DRUG INFORMATION JOURNAL (2008)
Analyzing incomplete longitudinal clinical trial data
G Molenberghs et al.
BIOSTATISTICS (2004)
Assessing and interpreting treatment effects in longitudinal clinical trials with missing data
CH Mallinckrodt et al.
BIOLOGICAL PSYCHIATRY (2003)
Type I error rates from mixed effects model repeated measures versus fixed effects anova with missing values imputed via last observation carried forward
CH Mallinckrodt et al.
DRUG INFORMATION JOURNAL (2001)